July 22
How Australia and the UK are building the next generation of biotech
Read more
Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.
Learn more about who we areA clinical stage company developing treatment for hot flashes in cancer survivors undergoing endocrine therapy
View ProjectDeveloping disease-modifying mitochondrial therapeutics for neurodegenerative disorders
View ProjectDeveloping the next generation of CAR-T cell therapies to treat solid cancers
View ProjectCombining non-opioid analgesics and biopolymers to deliver weeks of localised pain management
View ProjectUnlocking the potential of N-myristoyltransferase (NMT) to develop precision medicines for a range of diseases including cancer and viral infections
View ProjectGlyscend is developing novel non-absorbable polymers that are orally-delivered for the treatment of Type 2 Diabetes.
View ProjectThe ithree institute brings together a team of scientists with diverse skill sets who collectively address key challenges in the understanding and control of infectious diseases in humans and animals. Our senior scientists have recently refined the key research themes under which they will work together to increase their impact in the antibiotic resistance, food safety and infectious disease space.
ViewThe Heart Research Institute (HRI) is an internationally recognised research institute that performs cutting-edge cardiovascular research. The main focus of this research is to gain an understanding of the development and progression of atherosclerosis, the dominant cause of cardiovascular disease.
ViewBrandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.
Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.
Learn moreKraken Coding: from hospital pharmacy to health-tech founder on a mission to help clinicians make faster, safer decisions
Read moreDenteric Commences a Phase I Safety Study in Patients with Early Alzheimer’s Disease
Read more